Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

The herbal preparation may help manage alopecia by reducing inflammation and boosting the immune response.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Litfulo is recommended for treating severe alopecia areata in people 12 and older, as it helps hair regrowth.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Alopecia areata is linked to more chronic illnesses, a specific lamp helps with notalgia paresthetica itch, pycnogenol aids melasma treatment, and dupilumab improves severe atopic dermatitis in children.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

PRP is safer and has a lower relapse rate than TAC for treating alopecia areata.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Leflunomide and anthralin may effectively treat severe alopecia areata.